FdaApplication
NDA 213721
Identifiers
- fda_app_no: NDA213721
Properties
| Property | Value |
|---|---|
| applicant_name | RIGEL PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2020-09-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GAVRETO | PRALSETINIB | 100MG | CAPSULE;ORAL |
1 product